0001062993-23-018577.txt : 20230928
0001062993-23-018577.hdr.sgml : 20230928
20230928160605
ACCESSION NUMBER: 0001062993-23-018577
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230927
FILED AS OF DATE: 20230928
DATE AS OF CHANGE: 20230928
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hackman Jeffrey S.
CENTRAL INDEX KEY: 0001926254
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41403
FILM NUMBER: 231289532
MAIL ADDRESS:
STREET 1: 12 GILL STREET
STREET 2: SUITE 4650
CITY: WOBURN
STATE: MA
ZIP: 01801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Comera Life Sciences Holdings, Inc.
CENTRAL INDEX KEY: 0001907685
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 874706968
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12 GILL STREET
STREET 2: SUITE 4650
CITY: WOBURN
STATE: MA
ZIP: 01801
BUSINESS PHONE: (617)871-2101
MAIL ADDRESS:
STREET 1: 12 GILL STREET
STREET 2: SUITE 4650
CITY: WOBURN
STATE: MA
ZIP: 01801
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2023-09-27
0001907685
Comera Life Sciences Holdings, Inc.
CMRA
0001926254
Hackman Jeffrey S.
C/O COMERA LIFE SCIENCES HOLDINGS, INC.
12 GILL STREET, SUITE 4650
WOBURN
MA
01801
1
1
0
0
See Remarks.
0
Stock Option (Right to Purchase)
0.376
2023-09-27
4
A
0
600000
0
A
2033-09-27
Common Stock
600000
600000
D
25% of the shares underlying the stock option vest on September 27, 2024, with the remaining shares vesting on a monthly basis on the 27th day of each month thereafter, in each case, subject to continuous service to the issuer, such that the option shall be fully vested on September 27, 2027.
Chairman, President, and Chief Executive Officer.
/s/ Ryan M. Rourke Reed, Attorney-in-Fact
2023-09-28